Peptide having efficacy for remedying hypopigmentation and inhibiting adipogenesis, and use of same
AssigneeCaregen Co., Ltd.
InventorsYong Ji Chung, Eun Mi Kim, Eung Ji Lee, Kyoung Mi Cho
Life of this patent
Estimating the term…
Loading patent…
AssigneeCaregen Co., Ltd.
InventorsYong Ji Chung, Eun Mi Kim, Eung Ji Lee, Kyoung Mi Cho
Estimating the term…
A peptide formed from the amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2 shows a melanogenesis increment activity and an adipogenesis inhibitory activity. The peptide, by increasing phosphorylation of MITF, which is a transcription factor for increasing a tyrosinase expression, and CREB for increasing an MITF expression, consequently increases a tyrosinase expression and ultimately increases melanin synthesis. The peptide, by reducing the amount of fat accumulated inside a cell and reducing expressions of perilipin and PPARγ, which contribute to adipogenic mechanism, ultimately inhibits adipogenesis. A composition for remedying or treating melanin hypopigmentation, a composition comprising the peptide, and a pharmaceutical composition for treating or preventing obesity, are provided.
A peptide having a melanogenesis increasing activity, wherein the amino acid sequence of the peptide consists of the amino acid sequence of SEQ ID NO:
A peptide having an adipogenesis inhibiting activity, wherein the amino acid sequence of the peptide consists of the amino acid sequence of SEQ ID NO:
A peptide having a melanogenesis increasing activity, wherein the amino acid sequence of the peptide consists of the amino acid sequence of SEQ ID NO:
A peptide having an adipogenesis inhibiting activity, wherein the amino acid sequence of the peptide consists of the amino acid sequence of SEQ ID NO:
Dependencies are inferred from the claim text.